STOCK TITAN
  1. Home
  2. Sec-filings
  3. ELAN
  4. [Form 4] Elanco Animal Health Inc Insider Trading Activity

Elanco Animal Health (NYSE: ELAN) EVP granted new deferred stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc reported that Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi received a grant of 66.7690 Deferred Stock Units tied to Company common stock at a reference price of $22.1200 per unit. Each unit represents the right to receive one share of common stock or the cash equivalent, settling in cash or shares after termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan. Following this award, Modi holds a total of 9708.6964 Deferred Stock Units directly.

Positive

  • None.

Negative

  • None.
Insider Modi Rajeev A.
Role SEE REMARKS
Type Security Shares Price Value
Grant/Award Deferred Stock Units F1, F2 66.769 $22.12 $1K
Holdings After Transaction: Deferred Stock Units — 9,708.6964 shares (Direct)
Footnotes (2)
  1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
  2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Deferred Stock Units granted 66.7690 units Grant of Deferred Stock Units on 2026-08-07
Transaction price per unit $22.1200 Reference price for the Deferred Stock Unit grant
Total Deferred Stock Units after grant 9708.6964 units Direct holdings of Rajeev A. Modi following the award
Deferred Stock Units financial
"Each deferred stock unit represents the right to receive one share of Company common stock"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
cash equivalent financial
"the right to receive one share of Company common stock or the cash equivalent"
Executive Deferral and Stock Match Plan financial
"during a specified future year in accordance with Executive Deferral and Stock Match Plan"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did Elanco Animal Health (ELAN) report for Rajeev A. Modi?
Elanco reported that Rajeev A. Modi received a grant of 66.7690 Deferred Stock Units on 2026-08-07. These units are tied to Elanco common stock and increase his total deferred stock unit holdings.

How many Deferred Stock Units does Rajeev A. Modi hold after this Form 4 at ELAN?
After the reported award, Rajeev A. Modi holds 9708.6964 Deferred Stock Units directly. These units represent rights to receive Elanco common stock or cash in the future under the company’s deferral plan.

What does each Deferred Stock Unit represent in Elanco Animal Health (ELAN)'s Form 4 filing?
Each Deferred Stock Unit represents the right to receive one share of Elanco common stock or the cash equivalent. Settlement occurs following termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.

At what reference price were the Deferred Stock Units granted in Elanco (ELAN)'s Form 4?
The Deferred Stock Units were granted using a reference price of $22.1200 per unit. This figure is disclosed as the transaction price per unit for the 66.7690 Deferred Stock Units awarded to Rajeev A. Modi.

When will Rajeev A. Modi’s Deferred Stock Units from Elanco (ELAN) settle?
The Deferred Stock Units will settle in cash or shares of Elanco common stock after termination of employment or during a specified future year, consistent with the company’s Executive Deferral and Stock Match Plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Modi Rajeev A.
(Last)(First)(Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
450 ELANCO CIRCLE
(Street)
INDIANAPOLIS INDIANA 46221
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SEE REMARKS
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Stock Units(1)08/07/2026A66.769 (2) (2)Common Stock66.769$22.129,708.6964D
Explanation of Responses:
1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Remarks:
Executive Vice President U.S. Pet Health and Global Digital Transformation
/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi08/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR